Promise of new vascular-disrupting agents balanced with cardiac toxicity: is it time for oncologists to get to know their cardiologists?
van Heeckeren
Willem J
WJ
Bhakta
Shyam
S
Ortiz
Jose
J
Duerk
Jeff
J
Cooney
Matthew M
MM
Dowlati
Afshin
A
McCrae
Keith
K
Remick
Scot C
SC
D000970:Antineoplastic Agents / Q000009:adverse effects*; D042783:Endothelial Cells / Q000187:drug effects*; D006321:Heart / Q000187:drug effects*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D009943:Organophosphorus Compounds / Q000009:adverse effects*
D000970:Antineoplastic Agents; C455219:N-acetylcochinol-O-phosphate; D009943:Organophosphorus Compounds